Pacer Advisors Inc. Buys New Stake in Cantel Medical Corp. (CMD)

Pacer Advisors Inc. bought a new position in shares of Cantel Medical Corp. (NYSE:CMD) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 4,128 shares of the company’s stock, valued at approximately $322,000.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Integrated Investment Consultants LLC acquired a new position in Cantel Medical Corp. during the second quarter worth about $161,000. LS Investment Advisors LLC acquired a new position in Cantel Medical Corp. during the second quarter worth about $172,000. Airain ltd acquired a new position in Cantel Medical Corp. during the second quarter worth about $201,000. SG Americas Securities LLC acquired a new position in Cantel Medical Corp. during the second quarter worth about $230,000. Finally, First Quadrant L P CA acquired a new position in Cantel Medical Corp. during the second quarter worth about $233,000. Institutional investors own 84.28% of the company’s stock.

A number of equities analysts have issued reports on CMD shares. Sidoti upgraded shares of Cantel Medical Corp. from a “neutral” rating to a “buy” rating and set a $92.00 target price for the company in a research report on Wednesday, August 2nd. Zacks Investment Research upgraded shares of Cantel Medical Corp. from a “hold” rating to a “buy” rating and set a $83.00 target price for the company in a research report on Tuesday, August 1st. Benchmark Co. cut shares of Cantel Medical Corp. from a “buy” rating to a “hold” rating in a research report on Friday, June 9th. Finally, Needham & Company LLC restated a “hold” rating on shares of Cantel Medical Corp. in a research report on Thursday, June 8th. Four analysts have rated the stock with a hold rating and one has issued a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $91.67.

In other Cantel Medical Corp. news, Chairman Charles M. Diker sold 35,000 shares of the company’s stock in a transaction dated Wednesday, July 12th. The shares were sold at an average price of $75.52, for a total value of $2,643,200.00. Following the completion of the sale, the chairman now directly owns 3,114,520 shares of the company’s stock, valued at approximately $235,208,550.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 14.90% of the stock is currently owned by corporate insiders.

ILLEGAL ACTIVITY WARNING: This news story was reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of international trademark and copyright laws. The legal version of this news story can be read at https://sportsperspectives.com/2017/09/13/pacer-advisors-inc-buys-new-stake-in-cantel-medical-corp-cmd.html.

Cantel Medical Corp. (NYSE CMD) opened at 82.68 on Wednesday. Cantel Medical Corp. has a 12 month low of $68.19 and a 12 month high of $88.81. The firm’s 50-day moving average is $76.99 and its 200-day moving average is $76.58. The firm has a market cap of $3.43 billion, a PE ratio of 48.92 and a beta of 1.23.

Cantel Medical Corp. Profile

Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

Want to see what other hedge funds are holding CMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cantel Medical Corp. (NYSE:CMD).

Institutional Ownership by Quarter for Cantel Medical Corp. (NYSE:CMD)

Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply